- Presentations
- 5
- Markets
- 1
Aptiom is a brand of Eslicarbazepine marketed by Sumitomo Pharma, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Eslicarbazepine
- Brand owner
- Sumitomo Pharma
- Registered in
- United States
- Strengths and forms
- kit, 200 mg tablet, 400 mg tablet, 600 mg tablet, 800 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Aptiom kitOral | Sumitomo Pharma | US FDA | Available on request |
| Aptiom 200 mg tabletOral | Sumitomo Pharma | US FDA | Available on request |
| Aptiom 400 mg tabletOral | Sumitomo Pharma | US FDA | Available on request |
| Aptiom 600 mg tabletOral | Sumitomo Pharma | US FDA | Available on request |
| Aptiom 800 mg tabletOral | Sumitomo Pharma | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Aptiom
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.